Literature DB >> 17516024

Dimethylamino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs: synthesis and cytotoxicity studies.

Thomas Hickey1, James Claffey, Eoin Fitzpatrick, Megan Hogan, Clara Pampillón, Matthias Tacke.   

Abstract

From the carbolithiation of 6-N,N-dimethylamino fulvene (3a) and different lithiated N-heterocyclic compounds (N,N-dimethylaminomethylpyrrole, 1-methylimidazole and 2,4-[bis(N',N'-dimethylaminomethyl)]-N-methyl pyrrole), the corresponding lithium cyclopentadienide intermediate (4a-c) was formed. These three lithiated intermediates underwent a transmetallation reaction with TiCl4 resulting in dimethylamino-functionalised titanocenes 5a-c. When these titanocenes were tested against LLC-PK cells, the IC50 values obtained were of 13, and 63 microM for titanocenes 5b and 5c, respectively. The most cytotoxic titanocene in this paper (5a) with an IC50 value of 6.8 microM is found to be almost as cytotoxic as cis-platin, which showed an IC50 value of 3.3 microM, when tested on the epithelial pig kidney LLC-PK cell line, and titanocene 5c is approximately 400 times better than titanocene dichloride itself.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516024     DOI: 10.1007/s10637-007-9061-8

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  11 in total

Review 1.  Antitumor titanium compounds and related metallocenes.

Authors:  Francesco Caruso; Miriam Rossi
Journal:  Met Ions Biol Syst       Date:  2004

2.  Heteroaryl substituted titanocenes as potential anti-cancer drugs.

Authors:  Nigel Sweeney; William M Gallagher; Helge Müller-Bunz; Clara Pampillón; Katja Strohfeldt; Matthias Tacke
Journal:  J Inorg Biochem       Date:  2006-04-29       Impact factor: 4.155

3.  Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.

Authors:  K O'Connor; C Gill; M Tacke; F-J K Rehmann; K Strohfeldt; N Sweeney; J M Fitzpatrick; R W G Watson
Journal:  Apoptosis       Date:  2006-07       Impact factor: 4.677

4.  In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes.

Authors:  Gerhard Kelter; Nigel J Sweeney; Katja Strohfeldt; Heinz-Herbert Fiebig; Matthias Tacke
Journal:  Anticancer Drugs       Date:  2005-11       Impact factor: 2.248

5.  Activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride against tumor colony-forming units.

Authors:  Olaf Oberschmidt; Axel-R Hanauske; Franz-Josef K Rehmann; Katja Strohfeldt; Nigel Sweeney; Matthias Tacke
Journal:  Anticancer Drugs       Date:  2005-11       Impact factor: 2.248

6.  Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane.

Authors:  T Schilling; K B Keppler; M E Heim; G Niebch; H Dietzfelbinger; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

Review 7.  Titanium complexes in cancer treatment.

Authors:  Enrique Meléndez
Journal:  Crit Rev Oncol Hematol       Date:  2002-06       Impact factor: 6.312

8.  Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.

Authors:  Marize C Valadares; Aline L Ramos; Franz-Josef K Rehmann; Nigel J Sweeney; Katja Strohfeldt; Matthias Tacke; Mary L S Queiroz
Journal:  Eur J Pharmacol       Date:  2006-03-02       Impact factor: 4.432

9.  Phase II trial of titanocene dichloride in advanced renal-cell carcinoma.

Authors:  G Lümmen; H Sperling; H Luboldt; T Otto; H Rübben
Journal:  Cancer Chemother Pharmacol       Date:  1998       Impact factor: 3.333

10.  Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in mice.

Authors:  Iduna Fichtner; Clara Pampillón; Nigel J Sweeney; Katja Strohfeldt; Matthias Tacke
Journal:  Anticancer Drugs       Date:  2006-03       Impact factor: 2.248

View more
  2 in total

1.  Synthesis and cytotoxicity studies of steroid-functionalized titanocenes as potential anticancer drugs: sex steroids as potential vectors for titanocenes.

Authors:  Li Ming Gao; José L Vera; Jaime Matta; Enrique Meléndez
Journal:  J Biol Inorg Chem       Date:  2010-03-28       Impact factor: 3.358

Review 2.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.